Ambuja Cements Limited (AMBUJACEM.NS)
- Previous Close
644.45 - Open
644.00 - Bid --
- Ask --
- Day's Range
629.20 - 649.00 - 52 Week Range
375.75 - 649.00 - Volume
3,366,352 - Avg. Volume
3,627,659 - Market Cap (intraday)
1.572T - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
70.77 - EPS (TTM)
9.02 - Earnings Date Jun 25, 2024 - Jun 29, 2024
- Forward Dividend & Yield 2.50 (0.39%)
- Ex-Dividend Date Jul 7, 2023
- 1y Target Est
--
Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Mumbai, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.
www.ambujacement.com4,361
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: AMBUJACEM.NS
Performance Overview: AMBUJACEM.NS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMBUJACEM.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMBUJACEM.NS
Valuation Measures
Market Cap
1.59T
Enterprise Value
1.46T
Trailing P/E
71.37
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.23
Price/Book (mrq)
4.82
Enterprise Value/Revenue
4.84
Enterprise Value/EBITDA
34.26
Financial Highlights
Profitability and Income Statement
Profit Margin
9.82%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
322.32B
Net Income Avi to Common (ttm)
31.67B
Diluted EPS (ttm)
9.02
Balance Sheet and Cash Flow
Total Cash (mrq)
129.72B
Total Debt/Equity (mrq)
1.85%
Levered Free Cash Flow (ttm)
--
Company Insights: AMBUJACEM.NS
AMBUJACEM.NS does not have Company Insights